Key Insights

Highlights

Success Rate

92% trial completion (above average)

Published Results

59 trials with published results (9%)

Research Maturity

422 completed trials (61% of total)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 40/100

Termination Rate

5.1%

35 terminated out of 687 trials

Success Rate

92.3%

+5.8% vs benchmark

Late-Stage Pipeline

11%

77 trials in Phase 3/4

Results Transparency

14%

59 of 422 completed with results

Key Signals

59 with results92% success35 terminated

Data Visualizations

Phase Distribution

562Total
Not Applicable (363)
Early P 1 (2)
P 1 (25)
P 2 (95)
P 3 (33)
P 4 (44)

Trial Status

Completed422
Unknown109
Recruiting62
Terminated35
Not Yet Recruiting30
Withdrawn13

Trial Success Rate

92.3%

Benchmark: 86.5%

Based on 422 completed trials

Clinical Trials (687)

Showing 20 of 20 trials
NCT06687720Not ApplicableCompletedPrimary

A Clinical Study to Determine the Safety and Efficacy of An Oral Probiotic Supplementation in the Management of Irritable Bowel Syndrome With Protein Digestion.

NCT06801184RecruitingPrimary

Single-center Exploratory Study of the Intestinal Microbiota in Patients Treated for Irritable Bowel Syndrome With Predominant Constipation and Methane Production

NCT07722572Not ApplicableCompletedPrimary

Low-FODMAP vs Lactose-Gluten-Free Diet in Patients With Irritable Bowel Syndrome

NCT07716852Not ApplicableNot Yet RecruitingPrimary

Enzymax DuoBiotics for Irritable Bowel Syndrome

NCT07545772Phase 2RecruitingPrimary

A Study of Brenipatide (LY3537031) in Participants With Irritable Bowel Syndrome-Constipation (IBS-C)

NCT07545759Phase 2RecruitingPrimary

A Study of Brenipatide (LY3537031) in Participants With Irritable Bowel Syndrome-Diarrhea (IBS-D)

NCT07693907Not ApplicableNot Yet RecruitingPrimary

A Taiwan-Adapted Self-Management Program for Adults With Irritable Bowel Syndrome

NCT06706778Not ApplicableNot Yet Recruiting

The Mechanism Underlying the Analgesic Effect of the Music of IBS Pain

NCT02136745Not ApplicableCompletedPrimary

Effects of Relaxation Response Mind-body Intervention in Patients With IBS and IBD

NCT07676136Not ApplicableNot Yet Recruiting

A Pilot Study Using Gut-Directed Hypnotherapy for Hospitalized Patients

NCT06413004Not ApplicableRecruitingPrimary

Brachyspira and Intestinal Allergy-like Immune Reactions in Patients With Irritable Bowel Syndrome (IBS)

NCT07519395Phase 2RecruitingPrimary

A Study to Investigate Abdominal Symptoms With Camlipixant Compared With Placebo in Adults With Irritable Bowel Syndrome - Diarrhea (IBS-D) and Irritable Bowel Syndrome - Mixed (IBS-M)

NCT06268717Not ApplicableCompleted

GI Alpha-Gal Study

NCT06866106Not ApplicableRecruitingPrimary

Well-being in IBS: Strengths and Happiness (WISH) 2.0

NCT07494968Not ApplicableRecruitingPrimary

Defining Objective Markers of Compliance for Dietary Therapies in IBS

NCT00742118Not ApplicableCompletedPrimary

Effects of the Soluble Mediators of Mastocytes on the Intestinal Epithelial Barrier and of the Enteric Nervous System During the Syndrome of the Irritable Bowel

NCT05972317Not ApplicableRecruitingPrimary

The Stool Microbiome of Treated and Untreated IBS (Irritable Bowel Syndrome) Patients

NCT07465562Not ApplicableCompletedPrimary

Galactol® Enzyme Supplement for Post-Prandial Abdominal Bloating in Irritable Bowel Syndrome

NCT07607132Not ApplicableCompletedPrimary

Digitally Delivered Dietary Treament for Adult Patients With Irritable Bowel Syndrome: A Pilot Study

NCT06639984Phase 2RecruitingPrimary

Psyllium in Pediatric IBS

Scroll to load more

Research Network

Activity Timeline